• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Serum lactic dehydrogenase: a tumor marker for dysgerminoma.

作者信息

Schwartz P E, Morris J M

机构信息

Department of Obstetrics and Gynecology, Yale University, School of Medicine, New Haven, Connecticut.

出版信息

Obstet Gynecol. 1988 Sep;72(3 Pt 2):511-5.

PMID:3405571
Abstract

Four patients with stage IA-IIIC dysgerminomas were found to have preoperative elevations of serum lactic dehydrogenase (LDH) 1.8-51.5 times that of the upper limits of normal control values, in association with minor elevations of liver function tests (alkaline phosphatase, serum glutamic oxaloacetic transaminase, and serum glutamic pyruvic transaminase) up to 2.5 times normal control limits. Recognition of the association between this serum enzyme profile and dysgerminoma resulted in proper intraoperative staging and prompt initiation of chemotherapy in two patients. Failure to recognize the significance of the serum enzyme profile resulted in inadequate intraoperative staging and reoperation in one of the remaining patients. Serum LDH levels correlated with tumor size and stage of disease. Maximum tumor diameters in this series varied from 15-20 cm. A normal LDH level was present in an intraoperative serum sample obtained from a stage IA patient whose maximum tumor diameter was 8 cm. Selective elevation of LDH-1 and LDH-2 isoenzymes may provide additional evidence suggesting the presence of a dysgerminoma.

摘要

相似文献

1
Serum lactic dehydrogenase: a tumor marker for dysgerminoma.
Obstet Gynecol. 1988 Sep;72(3 Pt 2):511-5.
2
Serum lactic dehydrogenase and its isoenzymes in patients with ovarian dysgerminoma.
Int J Gynaecol Obstet. 1988 Dec;27(3):459-65. doi: 10.1016/0020-7292(88)90131-2.
3
Dysgerminoma and serum lactic dehydrogenase levels.无性细胞瘤与血清乳酸脱氢酶水平
Obstet Gynecol. 1983 Jan;61(1):99-101.
4
Ovarian germinoma (dysgerminoma) with elevated serum lactic dehydrogenase: case report and review of literature.血清乳酸脱氢酶升高的卵巢生殖细胞瘤(无性细胞瘤):病例报告及文献复习
Cancer. 1982 Mar 1;49(5):994-8. doi: 10.1002/1097-0142(19820301)49:5<994::aid-cncr2820490524>3.0.co;2-l.
5
[The diagnostic value of the assay of lactate dehydrogenese combined with other tumor markers in ovarian cancer].
Zhonghua Fu Chan Ke Za Zhi. 1994 Jun;29(6):336-9, 381.
6
Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.III期黑色素瘤的分子和生化检测:淋巴结清扫术后淋巴液的多标志物逆转录聚合酶链反应检测及术前血清乳酸脱氢酶水平
Br J Dermatol. 2008 Sep;159(3):597-605. doi: 10.1111/j.1365-2133.2008.08710.x. Epub 2008 Jul 4.
7
Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview.睾丸生殖细胞肿瘤中的乳酸脱氢酶及其同工酶:综述
Oncodev Biol Med. 1983;4(6):395-414.
8
Analysis of serum lactic dehydrogenase levels and its isoenzymes in ovarian dysgerminoma.
Gynecol Oncol. 1985 Sep;22(1):65-72. doi: 10.1016/0090-8258(85)90009-5.
9
Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.血清CA 125在非霍奇金淋巴瘤患者的分期及随访中具有临床价值:与肿瘤参数及疾病活动的相关性
Cancer. 1998 Feb 1;82(3):576-82.
10
[Diagnostic value of biochemical tumor markers in serum of patients with cancer of the ovary].
Nihon Sanka Fujinka Gakkai Zasshi. 1983 Mar;35(3):251-8.

引用本文的文献

1
Exosome-transmitted miR-30a-5p enhances cell proliferation, migration, and invasion in ovarian cancer.外泌体传递的miR-30a-5p增强卵巢癌细胞的增殖、迁移和侵袭能力。
Cell Div. 2023 Nov 1;18(1):20. doi: 10.1186/s13008-023-00099-2.
2
Ovarian dysgerminoma in pregnancy: A case report.妊娠合并卵巢未成熟畸胎瘤 1 例报告。
Medicine (Baltimore). 2021 Apr 9;100(14):e25364. doi: 10.1097/MD.0000000000025364.